Triumph Capital Management’s Medpace MEDP Stock Holding History

Triumph Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.83K	Hold	11	–	–	﹤0.01%	1306
2026 Q1	$5.28K	Buy	+11	New	+$5.63K	﹤0.01%	1285

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Triumph Capital Management's MEDP Position: Q2 2026 in Review

Triumph Capital Management held its Medpace (MEDP) position steady in Q2 2026 at 11 shares worth $5.83K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

Triumph Capital Management first reported a position in MEDP in Q1 2026 and has held it in 2 quarters since. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Triumph Capital Management held 11 shares of Medpace worth $5.83K as of Q2 2026.
Triumph Capital Management left its Medpace share count unchanged in Q2 2026.
Medpace made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1306 holding.
Triumph Capital Management first reported a position in Medpace in Q1 2026 and has held it in 2 quarters since.
699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.